Global X China Biotech ETF (HKG:2820)
71.78
+3.94 (5.81%)
Apr 1, 2026, 3:53 PM HKT
HKG:2820 Holdings Information
HKG:2820 is an equity ETF with a total of 44 individual holdings. The top holdings are Innovent Biologics stock at 12.99%, WuXi Biologics at 11.84%, BeOne Medicines AG at 11.42%, Akeso at 10.68%, and WuXi AppTec at 9.74%.
Total Holdings
44
Top 10 Percentage
85.59%
Asset Class
Equity
ETF Category
Health Care
Assets
607.18M
PE Ratio
40.01
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | HKG: 1801 | Innovent Biologics, Inc. | 12.99% |
| 2 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 11.84% |
| 3 | ONC | BeOne Medicines AG | 11.42% |
| 4 | HKG: 9926 | Akeso, Inc. | 10.68% |
| 5 | SHA: 603259 | WuXi AppTec Co., Ltd. | 9.74% |
| 6 | SHA: 600276 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 8.52% |
| 7 | HKG: 1177 | Sino Biopharmaceutical Limited | 7.20% |
| 8 | HKG: 1530 | 3SBio Inc. | 5.79% |
| 9 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 4.84% |
| 10 | HKG: 2228 | XtalPi Holdings Limited | 2.57% |
| 11 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2.51% |
| 12 | HKG: 0867 | China Medical System Holdings Limited | 1.97% |
| 13 | HKG: 1548 | Genscript Biotech Corporation | 1.55% |
| 14 | SHA: 688578 | Shanghai Allist Pharmaceuticals Co., Ltd. | 1.38% |
| 15 | SHE: 300347 | Hangzhou Tigermed Consulting Co., Ltd | 1.10% |
| 16 | HKG: 2617 | TransThera Sciences (Nanjing), Inc. | 1.07% |
| 17 | SHA: 603087 | Gan & Lee Pharmaceuticals. | 1.06% |
| 18 | SHE: 002252 | Shanghai RAAS Blood Products Co., Ltd. | 0.98% |
| 19 | SHE: 300255 | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 0.93% |
| 20 | SHA: 688331 | RemeGen Co., Ltd. | 0.86% |
| 21 | SHE: 300759 | Pharmaron Beijing Co., Ltd. | 0.75% |
| 22 | SHA: 688180 | Shanghai Junshi Biosciences Co., Ltd. | 0.64% |
| 23 | SHA: 600161 | Beijing Tiantan Biological Products Co., Ltd. | 0.57% |
| 24 | SHE: 000513 | Livzon Pharmaceutical Group Inc. | 0.46% |
| 25 | SHA: 688278 | Xiamen Amoytop Biotech Co., Ltd. | 0.44% |
As of Mar 30, 2026